1. Report Introduction
2. Peripheral Neuropathic Pain Epidemiology Overview at a Glance
3. Market Share Distribution of Peripheral Neuropathic Pain
4. Disease Background and Overview: Peripheral Neuropathic Pain
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Peripheral Neuropathic Pain Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Peripheral Neuropathic Pain by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
7.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
7.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
7.5. Diagnosed Cases of Peripheral Neuropathic Pain
7.6. Treated Cases of Peripheral Neuropathic Pain
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
8.1.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
8.1.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
8.1.5. Diagnosed Cases of Peripheral Neuropathic Pain
8.1.6. Treated Cases of Peripheral Neuropathic Pain
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
8.2.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
8.2.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
8.2.5. Diagnosed Cases of Peripheral Neuropathic Pain
8.2.6. Treated Cases of Peripheral Neuropathic Pain
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
8.3.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
8.3.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
8.3.5. Diagnosed Cases of Peripheral Neuropathic Pain
8.3.6. Treated Cases of Peripheral Neuropathic Pain
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
8.4.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
8.4.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
8.4.5. Diagnosed Cases of Peripheral Neuropathic Pain
8.4.6. Treated Cases of Peripheral Neuropathic Pain
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
8.5.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
8.5.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
8.5.5. Diagnosed Cases of Peripheral Neuropathic Pain
8.5.6. Treated Cases of Peripheral Neuropathic Pain
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Peripheral Neuropathic Pain
9.3. Sub-Type Specific cases of Peripheral Neuropathic Pain*
9.4. Sex- Specific Cases of Peripheral Neuropathic Pain*
9.5. Diagnosed Cases of Peripheral Neuropathic Pain
9.6. Treated Cases of Peripheral Neuropathic Pain
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.